Integrative Molecular Characterization of Malignant Pleural Mesothelioma, Cancer Discov, vol.8, pp.1548-1565, 2018. ,
Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus, J Thorac Oncol, 2020. ,
URL : https://hal.archives-ouvertes.fr/inserm-02447160
Sensitivity of pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response, Oncotarget, pp.44892-44904, 0296. ,
URL : https://hal.archives-ouvertes.fr/inserm-01285131
Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition, Clin Cancer Res, vol.20, pp.1323-1334, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02478599
Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma, Genome Med, vol.11, p.18, 2019. ,
Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses, Nat Med, vol.24, pp.1143-1150, 2018. ,
Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications, Nat Commun, vol.10, p.1333, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02090279
Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival, Mol Oncol, 2020. ,